AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To be a shareholder in Ermenegildo Zegna, you need to believe in the company’s ability to shift more of its growth into direct-to-consumer channels as wholesale slows, all while managing cost pressures. While the improved Q3 direct-to-consumer growth is encouraging for the brand’s most important short-term catalyst, it does not materially offset the ongoing risk of weaker wholesale performance, especially at Thom Browne, that could weigh on margins. Of recent announcements, the upcoming leadership transition at Thom Browne is especially relevant. The new CEO steps in as the wholesale segment faces headwinds, heightening execution risk during a crucial period when direct-to-consumer gains are needed to counterbalance softness elsewhere and preserve overall profit margins. However, investors should also be aware that cost discipline remains critical, especially as investments in talent and new stores elevate SG&A expenses…
Read the full narrative on Ermenegildo Zegna (it's free!)
Ermenegildo Zegna is projected to reach €2.2 billion in revenue and €127.2 million in earnings by 2028. This outlook assumes annual revenue growth of 3.4% and a €50.1 million increase in earnings from the current €77.1 million.
Uncover how Ermenegildo Zegna's forecasts yield a $10.74 fair value, a 3% upside to its current price.
All 1 fair value estimate from the Simply Wall St Community sits at €10.74 per share. Direct-to-consumer momentum stands out, but broader risks like wholesale weakness mean your outlook could look quite different.
Explore another fair value estimate on Ermenegildo Zegna - why the stock might be worth just $10.74!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com